Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now

Strides Pharma Standalone December 2022 Net Sales at Rs 386.51 crore, down 12.07% Y-o-Y

January 25, 2023 / 09:22 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Strides Pharma Science are:

Net Sales at Rs 386.51 crore in December 2022 down 12.07% from Rs. 439.56 crore in December 2021.

Quarterly Net Profit at Rs. 12.54 crore in December 2022 up 171.22% from Rs. 17.60 crore in December 2021.

EBITDA stands at Rs. 75.36 crore in December 2022 up 576.48% from Rs. 11.14 crore in December 2021.

Strides Pharma Science
Standalone Quarterly Resultsin Rs. Cr.
Dec'22Sep'22Dec'21
Net Sales/Income from operations386.51481.24439.56
Other Operating Income------
Total Income From Operations386.51481.24439.56
EXPENDITURE
Consumption of Raw Materials237.57285.81232.32
Purchase of Traded Goods3.689.690.68
Increase/Decrease in Stocks-26.0214.8439.20
Power & Fuel------
Employees Cost64.9570.0867.60
Depreciation22.2624.3526.23
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses60.73106.3596.12
P/L Before Other Inc. , Int., Excpt. Items & Tax23.34-29.88-22.59
Other Income29.7520.477.50
P/L Before Int., Excpt. Items & Tax53.10-9.41-15.09
Interest35.1034.6616.60
P/L Before Exceptional Items & Tax17.99-44.07-31.69
Exceptional Items------
P/L Before Tax17.99-44.07-31.69
Tax5.46-40.07-14.09
P/L After Tax from Ordinary Activities12.54-4.00-17.60
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period12.54-4.00-17.60
Equity Share Capital90.3090.2989.78
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS1.39-0.44-1.96
Diluted EPS1.39-0.44-1.96
EPS After Extra Ordinary
Basic EPS1.39-0.44-1.96
Diluted EPS1.39-0.44-1.96
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited